Exploring Clinical Updates Across Acne Vulgaris Therapeutic Development

Time: 2:30 pm
day: Conference Day One


  • Highlighting current treatment options and challenges in acne vulgaris
  • Exploring the role of ammonia oxidizing bacteria in inflammation
  • Investigational B244 delivered as a topical spray for efficacy and safety in mild to moderate acne vulgaris